NisreenSoufiMD
Pediatric Gastroenterology • Los Angeles, CAPediatric Hepatology and Liver Transplantation, Pediatric Nutrition
Physician
Dr. Soufi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4650 W Sunset Blvd
Los Angeles, CA 90027Phone+1 626-256-4673
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Pediatric Gastroenterology, 2011 - 2014- Washington University/B-JH/SLCH ConsortiumResidency, Pediatrics, 2008 - 2011
Damascus University Faculty of MedicineClass of 2007
Certifications & Licensure
CA State Medical License 2014 - 2025
MO State Medical License 2012 - 2025- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Gastroenterology
- American Board of Pediatrics Pediatric Transplant Hepatology
Publications & Presentations
PubMed
- 21 citationsLiver-specific loss of lipin-1-mediated phosphatidic acid phosphatase activity does not mitigate intrahepatic TG accumulation in miceGeorge G. Schweitzer, Zhouji Chen, Connie Gan, Kyle S. McCommis, Nisreen Soufi
Journal of Lipid Research. 2015-04-01 - 53 citationsOdevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial.Richard J Thompson, Henrik Arnell, Reha Artan, Ulrich Baumann, Pier Luigi Calvo
The Lancet. Gastroenterology & Hepatology. 2022-09-01 - 32 citationsMaralixibat for the treatment of PFIC: Long-term, IBAT inhibition in an open-label, Phase 2 study.Kathleen M Loomes, Robert H Squires, Deirdre Kelly, Sanjay Rajwal, Nisreen Soufi
Hepatology Communications. 2022-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
